Document is current
Any future updates will be listed below
-
Authors
Agarwal, Anubha https://orcid.org/0000-0002-7090-5601
Peters, Sanne A. E.
Chandramouli, Chanchal
Lam, Carolyn S. P.
Figtree, Gemma A.
Arnott, Clare
-
Funding
Funding for this research was provided by:
Feinberg School of Medicine (Institute of Global Health)
- License Information
-
More Information
Article History
Accepted: 9 June 2021
First Online: 2 July 2021
Declarations
:
: Anubha Agarwal plans to submit a patent for heart failure polypills including for heart failure with reduced ejection fraction.Sanne AE Peters reports no conflicts of interest.Chanchal Chandramouli reports grants from National Medical Research Council Singapore, philanthropic research grants from Lee Foundation Singapore other from Boehringer Ingelheim and Sanofi Aventis.Carolyn SP Lam reports grants from National Medical Research Council Singapore, non-financial support from Boston Scientific, non-financial support and other from Bayer, non-financial support from Thermofisher, non-financial support from Vifor Pharma, other from Takeda, other from Merck, other from Astra Zeneca, other from Janssen Research & Development, other from LLC, other from Menarini, other from Boehringer Ingelheim, other from Abbott Diagnostics, other from DC Devices, other from PCT/SG2016/050217 Patent pending, outside the submitted work.Gemma A Figtree has received research support from the cofunded Australian National Health and Medical Research Council and Heart Foundation fellowship and Heart Research Australia; and has received compensation from Janssen for serving on the adjudication panel of the CANVAS Program.Clare Arnott is supported by a NSW Health Early-Mid Career Fellowship and NHMRC/MRFF Priority Investigator Grant.
: Informed consent was obtained in all studies with human participants performed by any of the authors. This article does not contain any studies with animal subjects.
